These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38521738)

  • 1. Differential regulation of human thrombospondin-1 upon systemic desmopressin versus endotoxin challenge.
    Scheuba A; Zagrapan B; Martelanz L; Eder V; Ibrahim N; Bleichert S; Knöbl V; Hayden H; von Kuenheim S; Münch K; Buchtele N; Schoergenhofer C; Kovacevic KD; Lackner E; Drucker C; Neumayer C; Jilma B; Brostjan C
    Thromb Res; 2024 May; 237():205-208. PubMed ID: 38521738
    [No Abstract]   [Full Text] [Related]  

  • 2. Desmopressin: a nontransfusional treatment of hemophilia and von Willebrand disease.
    Mannucci PM; Cattaneo M
    Haemostasis; 1992; 22(5):276-80. PubMed ID: 1478539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of desmopressin on plasma factor VIII and von Willebrand factor concentrations in Greyhounds.
    Sato I; Parry BW
    Aust Vet J; 1998 Dec; 76(12):809-12. PubMed ID: 9972432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of adjusted weight-based dosing of desmopressin (1-deamino-8-d-arginine vasopressin in type 1 von Willebrand disease.
    Seaman CD
    Blood Coagul Fibrinolysis; 2023 Oct; 34(7):462-464. PubMed ID: 37823430
    [No Abstract]   [Full Text] [Related]  

  • 5. A retrospective study of the utility of desmopressin (1-deamino-8-D-arginine vasopressin) trials in the management of patients with von Willebrand disorder.
    Shortt J; Opat SS; Gorniak MB; Aumann HA; Collecutt MF; Street AM
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e181-3. PubMed ID: 19016919
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of desmopressin (DDAVP) on platelet membrane glycoprotein expression in patients with von Willebrand's disease.
    Gordz S; Mrowietz C; Pindur G; Park JW; Jung F
    Clin Hemorheol Microcirc; 2005; 32(2):83-7. PubMed ID: 15764817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desmopressin improves platelet activity in acute intracerebral hemorrhage.
    Naidech AM; Maas MB; Levasseur-Franklin KE; Liotta EM; Guth JC; Berman M; Rosenow JM; Lindholm PF; Bendok BR; Prabhakaran S; Bernstein RA; Kwaan HC
    Stroke; 2014 Aug; 45(8):2451-3. PubMed ID: 25005444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No influence of blood group on the responsiveness to desmopressin in type I "platelet normal" von Willebrand's disease.
    Castaman G; Rodeghiero F
    Thromb Haemost; 1995 Mar; 73(3):551-2. PubMed ID: 7667843
    [No Abstract]   [Full Text] [Related]  

  • 9. The response of plasma von Willebrand factor to desmopressin (DDAVP) is related to the platelet levels of von Willebrand factor.
    Lattuada A; Varanukulsak P; Castaman GC; Mannucci PM
    Thromb Res; 1992 Aug; 67(4):467-71. PubMed ID: 1412225
    [No Abstract]   [Full Text] [Related]  

  • 10. von Willebrand factor release induced by endotoxin.
    Gralnick HR; McKeown LP; Wilson OM; Williams SB; Elin RJ
    J Lab Clin Med; 1989 Jan; 113(1):118-22. PubMed ID: 2491879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmopressin: do we now know its role?
    Tyers GF
    Can J Surg; 1990 Feb; 33(1):5-6. PubMed ID: 2302601
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantification of the relationship between desmopressin concentration and Von Willebrand factor in Von Willebrand disease type 1: A pharmacodynamic study.
    Heijdra JM; Cloesmeijer ME; de Jager NCB; Leebeek FWG; Kruip MHJA; Cnossen MH; Mathôt RAA;
    Haemophilia; 2022 Sep; 28(5):814-821. PubMed ID: 35526239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease.
    Atiq F; Heijdra J; Snijders F; Boender J; Kempers E; van Heerde WL; Maas DPMSM; Krouwel S; Schoormans SC; de Meris J; Schols SEM; van Galen KPM; van der Bom JG; Cnossen MH; Meijer K; Fijnvandraat K; Eikenboom J; Leebeek FWG
    Blood Adv; 2022 Sep; 6(18):5317-5326. PubMed ID: 35446929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Desmopressin testing in children with von Willebrand syndrome in haemostaseologic centers of Saxonia, Saxonia-Anhalt and Thuringia].
    Huhn B; Hofmann A; Hofmann K; Sirb H; Aumann V; Kentouche K; Sauerbrey A; Franke D; Kuhlisch E; Knöfler R
    Hamostaseologie; 2009 Oct; 29 Suppl 1():S98-102. PubMed ID: 19763352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired Von Willebrand syndrome and response to desmopressin.
    Biguzzi E; Siboni SM; Peyvandi F
    Haemophilia; 2018 Jan; 24(1):e25-e28. PubMed ID: 29239101
    [No Abstract]   [Full Text] [Related]  

  • 16. Desmopressin (dDAVP): a powerful general hemostatic agent?
    Drouet L; Scrobohaci ML; Boudaoud S; Vilain G
    Nouv Rev Fr Hematol (1978); 1989; 31(2):163-5. PubMed ID: 2528120
    [No Abstract]   [Full Text] [Related]  

  • 17. Desmopressin reverses effects of dextran on von Willebrand factor.
    Flordal PA; Ljungström KG; Svensson J
    Thromb Haemost; 1989 Jun; 61(3):541. PubMed ID: 2477910
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood group significantly influences von Willebrand factor increase and half-life after desmopressin in von Willebrand disease Vicenza.
    Castaman G; Tosetto A; Eikenboom JC; Rodeghiero F
    J Thromb Haemost; 2010 Sep; 8(9):2078-80. PubMed ID: 20561182
    [No Abstract]   [Full Text] [Related]  

  • 19. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years.
    Mannucci PM
    Blood; 1997 Oct; 90(7):2515-21. PubMed ID: 9326215
    [No Abstract]   [Full Text] [Related]  

  • 20. Review of clinical experience of desmopressin in patients with congenital and acquired bleeding disorders.
    Cattaneo M
    Eur J Anaesthesiol Suppl; 1997 Mar; 14():10-4; discussion 14-8. PubMed ID: 9088829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.